-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The synthesis of 5-methyl-6,7-dihydro-5H-cyclopentapyrazine, also known as MK-801, is an important compound in the field of pharmaceuticals and neuroscience research.
The compound was first synthesized in 1988 by a team of researchers led by Dr.
Bryan Roth at the University of Virginia.
Since then, it has been widely studied for its potential therapeutic effects on various neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression.
There are several synthetic routes to obtain 5-methyl-6,7-dihydro-5H-cyclopentapyrazine.
One of the most commonly used methods is the Williamson ether synthesis, which involves the reaction of phenol with an aldehyde in the presence of sodium hydroxide and the use of ether as a solvent.
Another approach is the Grignard reaction, which involves the preparation of a Grignard reagent from a halogenated alkane and the subsequent reaction with an amine.
In this article, we will discuss two synthetic routes to obtain 5-methyl-6,7-dihydro-5H-cyclopentapyrazine, the Williamson ether synthesis and the Grignard reaction.
We will also provide a detailed overview of the synthesis process, starting from the preparation of the necessary starting materials and the steps involved in the synthesis itself.
Williamson ether synthesis
The Williamson ether synthesis is a commonly used method for the synthesis of 5-methyl-6,7-dihydro-5H-cyclopentapyrazine.
The synthesis involves the reaction of phenol with an aldehyde in the presence of sodium hydroxide and the use of ether as a solvent.
The synthesis of 5-methyl-6,7-dihydro-5H-cyclopentapyrazine via the Williamson ether synthesis involves the following steps:
- Preparation of the starting materials: phenol and the corresponding aldehyde are the starting materials for the synthesis.
These materials can be purchased from a chemical supplier or synthesized in the laboratory. - Preparation of the reaction mixture: a mixture of phenol, the aldehyde, and sodium hydroxide is prepared in a reaction flask.
The reaction mixture is then stirred and heated to a temperature of about 80-90°C. - Williamson ether synthesis: the reaction mixture is then treated with ether, which acts as a solvent for the reaction.
The reaction is exothermic, and care should be taken to maintain the temperature at around 80-90°C. - Workup: the reaction mixture is allowed to cool, and the ether is separated from the aqueous layer using a separatory funnel.
The ether layer is then dried with anhydrous sodium sulfate and filtered. - Purification: the resulting solution is then subjected to column chromatography using a mixture of ethyl acetate and methanol as the eluent.
The fractions containing the desired product are collected and concentrated to obtain the pure product.
Grignard reaction
Another approach to synthesize 5-methyl-6,7-dihydro-5H-cyclopentapyrazine is the Grignard reaction.
This method involves the preparation of a Grignard reagent from a halogenated alkane and the subsequent reaction with an amine.
The synthesis of 5-methyl-6,7-dihydro-5H-cyclopentapyrazine via the Grignard reaction involves the following steps:
- Preparation of the starting materials: a halogenated alkane, such as bromoethane, and